Effects of chronic administration of D-003, a mixture of sugar cane wax high molecular acids, in beagle dogs

Drugs under Experimental and Clinical Research

Volumn 30, Issue 2, 2004, Pages 75-88

  Gamez R ^a   Mas R ^a   Noa, M ^a   Menendez R ^a   Garcia H ^a   Gonzalez J ^a   Perez Y ^a   Goicochea, E ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ALIPHATIC CARBOXYLIC ACID; COLLAGEN; D 003; KAOLIN; SACCHARUM OFFICINARUM EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING TIME; BLOOD CHEMISTRY; BLOOD CLOTTING; BODY WEIGHT; CHRONOPHARMACOLOGY; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG PURIFICATION; DRUG SCREENING; FEMALE; FOOD INTAKE; HISTOPATHOLOGY; MALE; MOLECULAR WEIGHT; NONHUMAN; PROTHROMBIN TIME; SUGARCANE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOPLASTIN TIME; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANIMALS; BEHAVIOR, ANIMAL; CHOLESTEROL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; FEMALE; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; TRIGLYCERIDES;

EID: 3142690967     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Anderson K.M., Wilson P.W.F., Odell P.M., et al. An updated coronary risk profile. A statement for health professionals. Circulation, 83, 356, 1991.
2. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results II. The relationship of reduction in the incidence of coronary heart disease to cholesterol lowering. JAMA, 251, 365, 1984.
3. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet, 344, 1383, 1994.
4. Sacks F.M., Pfeffer M.A., Moy L.A., et al. for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N. Engl. J. Med., 335, 1001, 1996.
5. Shepherd S., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med., 333, 1301, 1995.
6. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial. Lancet, 360, 7, 2002.
7. Falk E., Fernández-Ortiz A. Role of thrombosis in atherosclerosis and its complications. Am. J. Cardiol., 75(6), 3B, 1995.
8. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy-1: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ, 308, 81, 1994.
9. Schafer A. Antiplatelet therapy. Am. J. Med., 101, 199, 1996.
10. González L., Marrero D., Laguna A., et al., inventors; Laboratorios Dalmer SA, assignee. Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses. Republic of South Africa patent 98-2744. December 30, 1998.
11. Gámez R., Mendoza S., Más R., et al. Dose-dependent cholesterol-lowering effects of D-003 on normocholesterolemic rabbits. Curr. Ther. Res. Clin. Exp., 61, 8, 2000.
12. Mendoza S., Gámez R., Noa M., et al. The effects of D-003 and policosanol on the lipid profile and endothelemia cells in normocholesterolemic rabbits: A head-to-head comparison. Curr. Ther. Res., 62, 209, 2001.
13. Menéndez R., Más R., Amor A.M., et al. Inhibition of cholesterol biosynthesis in cultured fibroblasts by D-003, a mixture of very long chain saturated fatty acids. Pharmacol. Res., 44, 299, 2001.
14. Molina V., Arruzazabala M.L., Carbajal D., et al. Antithrombotic effects of D003. Pharmacol. Res., 42, 137, 2000.
15. Molina V., Arruzazabala M.L., Carbajal D., Mas R. D-003, a potential antithrombotic compound isolated from sugar cane wax with effects on arachidonic acid metabolites. Prostaglandins Leukot. Essent. Fatty Acids, 67(1), 19, 2002.
16. Castaño G., Mas R., Fernández L., et al. Assessment of the effects of D-003, a new antiplatelet and hypocholesterolemic compound on healthy volunteers: A phase I clinical study. Drugs R&D, 3, 337, 2002.
17. Arruzazabala M.L., Carbajal D., Mas R., et al. Effects of D-003, a new compound purified from sugar cane wax, on platelet aggregation in healthy volunteers: A randomized, double-blinded clinical study. Clin. Drug Invest., 23, 107, 2002.
18. Castaño G., Menéndez R., Mas R., et al. Effects of D-003 on lipid profile and lipid peroxidation in healthy volunteers. Clin. Drug Invest., 23, 193, 2003.
19. Gerson R., MacDonald J., Alberts W., et al. Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl coenzyme A reductase inhibitors. Am. J. Med., 87 (Suppl. 4a), 28, 1989.
20. Bhatnagar D. Lipid-lowering drugs in the management of hyperlipidaemia. Pharmacol. Ther., 79, 205, 1998.
21. Davenport R.J., Dennis M.S., Warlow C.P. Gastrointestinal hemorrhage after acute stroke. Stroke, 27, 421, 1996.
22. Diez-Tejedor E., Alonso de Lecinana M., Counsell C., Sandercock P. Antithrombotic treatment in acute ischemia stroke. Neurologia, 10, 48, 1995.
23. Gámez R., Más R., Noa M., et al. Acute and subchronic oral toxicity of D-003 in rats. Toxicol. Letts., 118, 31, 2000.
24. Gámez R., González J.E., Rodeiro I., et al. In vivo genotoxic evaluation of D-003, a mixture of very long-chain aliphatic acids. J. Med. Food, 4, 85, 2001.
25. Gámez R., Rodeiro I., Fernández I. A preliminary evaluation of the cytotoxic and genotoxic potential of D-003, a mixture of very long chain fatty acids. Teratogen. Carcinogen. Mutagen., 21, 85, 2001.
26. Gámez R., Mas R., Noa M., et al. Six-month toxicity study of oral administration of D-003 in Sprague Dawley rats. Drugs R&D, 3, 375, 2002.
27. ICH Harmonised Tripartite Guideline. Duration of chronic toxicity testing in animals (rodents and nonrodent toxicity testing). Recommended for adoption at Step 4 of the ICH Process on September 2, 1998 by the ICH Steering Committee.
28. Rehg J.E., Toth L.A. Rodent quarantine programs: Purpose, principles and practice. Lab. An. Sci., 48, 438, 1998.
29. Landsdown A.B. Animal husbandry. In: Anderson D. (Ed.). "Experimental Toxicology: The Basic Issues." BIBRA, Surrey, 1993, pp. 101.
30. Chhabra R.S., Huff J.E., Schwetz B.S., Selkirk J. An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Program. Environ. Health Persp., 86, 313, 1990.
31. EPA: Health effects test guidelines. OPPTS 870.4100, Chronic toxicity. United States Environmental Protection Agency, prevention, pesticides and toxic substances (7101), EPA 712C-96-210, 1996.
32. Morton B., Abbot D., Barclay R., et al. Removal of blood from laboratory mammals and birds. Lab. Animals, 27, 1, 1993.
33. Voss G., Sachsse K. Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by modified acetylthiocoline-DTNB procedure. Toxicol. Appl. Pharmacol., 16, 764, 1970.
34. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 194, 927, 1962.
35. Evans L.G., Butler W.H. Histopathology in safety evaluation. In: "Experimental Toxicology. The Basic Issues." Anderson, D. (Ed.). BIBRA, Surrey, 1993, pp. 119-129.
36. Wolford S.T., Schoer R.A., Gohs F.X., Gallo P.P. Reference range database for serum chemistry and haematology values in laboratory animals. J. Toxicol. Environ. Health, 18, 161, 1986.
37. Matsuzawa T., Nomura M., Unno T. Clinical pathology references ranges of laboratory animals. J. Vet. Med. Sci., 55, 351, 1993.
38. Haggerty G.C., Thomassen R.W., Chengelis C.P. The Dog. In: Gad S.C., Chengelis C.P. (Eds.). "Animal Models in Toxicology." Marcel Dekker Inc., New York, 1992, pp. 567-657.
39. Mesa A.R., Más R., Noa M., et al. Toxicity of policosanol in beagle dogs: One-year study. Toxicol. Lett., 73, 81, 1994.
40. Alemán C.L., Mas R., Noa M., et al. Carcinogenicity of policosanol in Sprague Dawley rats: A 24-month study. Teratog. Carcinog. Mutagen, 14, 239, 1994.
41. Rodriguez M., García H. Teratogenic and reproductive studies of policosanol in the rat and rabbit. Teratog. Carcinog. Mutagen., 14, 107, 1994.